0001104659-20-022138.txt : 20200214
0001104659-20-022138.hdr.sgml : 20200214
20200214212852
ACCESSION NUMBER: 0001104659-20-022138
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200210
FILED AS OF DATE: 20200214
DATE AS OF CHANGE: 20200214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gionco David
CENTRAL INDEX KEY: 0001456864
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35619
FILM NUMBER: 20623082
MAIL ADDRESS:
STREET 1: 9 HOWELL DRIVE
CITY: FAR HILLS
STATE: NJ
ZIP: 07931
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STEMLINE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001264587
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450522567
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
STREET 2: ELEVENTH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 646-502-2311
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
a4.xml
4
X0306
4
2020-02-10
0
0001264587
STEMLINE THERAPEUTICS INC
STML
0001456864
Gionco David
C/O STEMLINE THERAPEUTICS, INC.
750 LEXINGTON AVENUE, ELEVENTH FLOOR
NEW YORK
NY
10022
0
1
0
0
Chief Accounting Officer
Common Stock
2020-02-10
4
A
0
107317
0
A
342738
D
The 107,317 shares will vest in three installments as follows: 35,773 shares will vest on January 20, 2021; 35,772 shares will vest on February 16, 2022, and 35,772 shares will vest on March 29, 2023.
Of the shares listed, 287,719 shares are restricted stock.
/s/ David Gionco
2020-02-14